Medicament composition for treating male climacteric syndrome and delaying age

Abstract

The invention discloses a pharmaceutical composition for treating male menopause syndrome and delaying senility. The pharmaceutical composition is prepared from epimedium, rhodiola root, sea buckthorne, fructus alpiniae oxyphyllae, Chinese yam, ginkgo seed, ganoderma lucidum spore powder, fleece-flower root, dogwood, salvia miltiorrhiza, radix morindae and eucommia bark. The raw material drugs are added with the prior accessories, and prepared into various clinically acceptable dosage forms by the prior process, such as capsule, granule, tablet, oral liquid preparation, and the like. The invention also provides application of the pharmaceutical composition to prepare medicaments for treating the male menopause syndrome and delaying the senility, enhancing immune function, and alleviating fatigue.

Description

technical field

[0001] The invention relates to a traditional Chinese medicine composition, in particular to a medicinal composition for treating male climacteric syndrome, delaying aging, enhancing immunity and relieving fatigue. Background technique

[0002] As people grow older, they show physiological phenomena in different periods. Andropause is a relatively long and unavoidable age stage transitioning to old age. The obvious physiological changes in this period are from vigorous reproductive function to weakening. Some physiological changes or subjective symptoms are not very obvious, so the physiological changes and related diseases of male menopause are easily overlooked. With the progress of society and the acceleration of the pace of work and life, the symptoms and diseases related to male menopause are on the rise, such as cardiovascular disease, diabetes, and Alzheimer's disease, which reminds the urgency of strengthening the care of menopausal men.

[0003] Dur...